These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12582449

  • 1. Frovatriptan: a selective type 1B/1D serotonin receptor agonist for the treatment of migraine headache.
    Cole P, Rabasseda X.
    Drugs Today (Barc); 2002 Sep; 38(9):615-29. PubMed ID: 12582449
    [Abstract] [Full Text] [Related]

  • 2. Frovatriptan: a review of its use in the acute treatment of migraine.
    Sanford M.
    CNS Drugs; 2012 Sep 01; 26(9):791-811. PubMed ID: 22900951
    [Abstract] [Full Text] [Related]

  • 3. Frovatriptan review.
    Markus F, Mikko K.
    Expert Opin Pharmacother; 2007 Dec 01; 8(17):3029-33. PubMed ID: 18001261
    [Abstract] [Full Text] [Related]

  • 4. Frovatriptan.
    Easthope SE, Goa KL.
    CNS Drugs; 2001 Dec 01; 15(12):969-76; discussion 977-8. PubMed ID: 11735616
    [Abstract] [Full Text] [Related]

  • 5. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.
    Balbisi EA.
    Int J Clin Pract; 2004 Jul 01; 58(7):695-705. PubMed ID: 15311727
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic evaluation of frovatriptan.
    Negro A, Lionetto L, Casolla B, Lala N, Simmaco M, Martelletti P.
    Expert Opin Drug Metab Toxicol; 2011 Nov 01; 7(11):1449-58. PubMed ID: 21929465
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD, Elkind AH, Schreiber C, Keywood C.
    Neurology; 2004 Jul 27; 63(2):261-9. PubMed ID: 15277618
    [Abstract] [Full Text] [Related]

  • 8. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
    Géraud G, Spierings EL, Keywood C.
    Headache; 2002 Apr 27; 42 Suppl 2():S93-9. PubMed ID: 12028325
    [Abstract] [Full Text] [Related]

  • 9. Frovatriptan: pharmacological differences and clinical results.
    Rapoport AM.
    Curr Med Res Opin; 2001 Apr 27; 17 Suppl 1():s68-70. PubMed ID: 12463282
    [Abstract] [Full Text] [Related]

  • 10. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
    Guidotti M, Ravasio R.
    Clin Drug Investig; 2009 Apr 27; 29(11):693-702. PubMed ID: 19813772
    [Abstract] [Full Text] [Related]

  • 11. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.
    Headache; 2009 Oct 27; 49(9):1298-314. PubMed ID: 19788471
    [Abstract] [Full Text] [Related]

  • 12. Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.
    Elkind AH, MacGregor EA.
    Expert Rev Neurother; 2008 May 27; 8(5):723-36. PubMed ID: 18457529
    [Abstract] [Full Text] [Related]

  • 13. Frovatriptan: a review of drug-drug interactions.
    Buchan P, Wade A, Ward C, Oliver SD, Stewart AJ, Freestone S.
    Headache; 2002 Apr 27; 42 Suppl 2():S63-73. PubMed ID: 12028322
    [Abstract] [Full Text] [Related]

  • 14. Dose range-finding studies with frovatriptan in the acute treatment of migraine.
    Rapoport A, Ryan R, Goldstein J, Keywood C.
    Headache; 2002 Apr 27; 42 Suppl 2():S74-83. PubMed ID: 12028323
    [Abstract] [Full Text] [Related]

  • 15. Clinical efficacy of frovatriptan: placebo-controlled studies.
    Ryan R, Géraud G, Goldstein J, Cady R, Keywood C.
    Headache; 2002 Apr 27; 42 Suppl 2():S84-92. PubMed ID: 12028324
    [Abstract] [Full Text] [Related]

  • 16. Frovatriptan: a review.
    Goldstein J.
    Expert Opin Pharmacother; 2003 Jan 27; 4(1):83-93. PubMed ID: 12517245
    [Abstract] [Full Text] [Related]

  • 17. Frovatriptan for the acute treatment of migraine: a dose-finding study.
    Goldstein J, Keywood C, 251/96/14 Study Group.
    Headache; 2002 Jan 27; 42(1):41-8. PubMed ID: 12005274
    [Abstract] [Full Text] [Related]

  • 18. Frovatriptan in the practice of office-based neurologists/pain therapists: Results of postmarketing surveillance study ALADIN.
    Wallasch TM.
    Adv Ther; 2010 Jan 27; 27(1):56-62. PubMed ID: 20140543
    [Abstract] [Full Text] [Related]

  • 19. Pharmacology of the selective 5-HT(1B/1D) agonist frovatriptan.
    Comer MB.
    Headache; 2002 Apr 27; 42 Suppl 2():S47-53. PubMed ID: 12028320
    [Abstract] [Full Text] [Related]

  • 20. Factors associated with frovatriptan response in patients with migraine: A prospective, observational study.
    Seo JG, Park SP.
    Cephalalgia; 2016 Apr 27; 36(5):493-8. PubMed ID: 26170008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.